Another randomization study also determined that carriers of the ADH1B*2 allele had not only lower rates of alcohol consumption but also decreased scores of histologic steatosis, lobular inflammation, and NAFLD activity. The gene discussed is ADH1B; the disease is metabolic dysfunction-associated steatotic liver disease.